About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05649631

The Effect of Low Sodium Diet on Idiopathic Hyperaldosteronism

This study was a single-center randomized controlled trial which lasted 14 days and consisted of two stages (run-in period (stage I) and intervention period (stage II) each contain 7 days without pota...

Lead sponsor: Shanghai Jiao Tong University School of Medicine•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Shanghai Jiao Tong University School of Medicine

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. 18-70 years;
•2. diagnosed as PA by SIT;
•3. no lateralization of aldosterone secretion during AVS;
•4. serum potassium ≥ 2.8 mmol/L after the stage I.

Exclusion Criteria

•1. Impaired renal function (Ccr\<60 ml/min);
•2. Impaired liver function (ALT, AST \> 2.5 times upper limit of normal);
•3. Patients with heart failure (NYHA≥ class 3 or EF \< 50%);
•4. Patients with stroke or acute infarction in the last 6 months;
•5. Patients who are pregnant or breastfeeding;
•6. Patients who cannot tolerate dietary arrangements;
•7. Patients with history of malignant tumors in the last 6 months.

Related studies

COMPLETEDPhase 2

Calcium Channel Blockade in Primary Aldosteronism

NCT04179019 · Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)

Spatial Proteomics Profiles of Aldosterone-producing Adenoma and Unilateral Hyperplasia

NCT05927961 · Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)

Superselective Adrenal Arterial Embolization for Bilateral Idiopathic Hyperaldosteronism: A Prospective Cohort Study

NCT05186675 · Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)

Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism

NCT03174847 · Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 14, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment50

Start dateJul 2021

Last updatedDec 14, 2022

Condition

Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)

Locations shown

Yiran Jiang

Shanghai, Shanghai Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 14, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions